PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-06

Date Title Company
06-May-2026 Patients benefit as the Royal Hospital for Neuro-disability introduces innovative predictive technology to support earlier recognition of infection risk Sanome
06-May-2026 BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates Businesswire
06-May-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-May-2026 FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media Businesswire
06-May-2026 Hidden Inflammation Around Breast Implants Karl Landsteiner University
06-May-2026 Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ) ACCESS Newswire
06-May-2026 Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness ACCESS Newswire
06-May-2026 Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands Uniphar
06-May-2026 Nurses Week Report: FBI Cyber Warning Puts Hospital Nurses' Downtime Readiness in Focus ACCESS Newswire
06-May-2026 Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline Businesswire
06-May-2026 Vitalant and San Diego  Blood Bank Complete Strategic Merger Vitalant
06-May-2026 Link Biologics strengthens IP position for Link_TSG6 with US patent Notice of Allowance and University of Manchester IP assignment Link Biologics
06-May-2026 New scientific article published on TrkA-NAM ACD137 against osteoarthritic pain AlzeCure Pharma AB
06-May-2026 Spago Nanomedical's phase I/IIa study Tumorad-01 meets a primary endpoint and provides further visible tumor uptake Spago Nanomedical
06-May-2026 Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) ACCESS Newswire
06-May-2026 Signadori Bio Raises €11 Million Seed Round to Advance Next-Generation Solid Tumour Platform Businesswire
06-May-2026 New Membrane Technology Hub is Tackling Cancer Drugs, Carbon Capture and the Global Water Crisis Crowdhelix
06-May-2026 Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection ACCESS Newswire
06-May-2026 Dr. Ran Rubinstein Introduces Renuva(R): A Breakthrough Non-Surgical Fat Restoration Treatment in New York and New Jersey ACCESS Newswire
06-May-2026 Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update Businesswire